CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

164 hedge funds and large institutions have $2.44B invested in Celldex Therapeutics in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 60 increasing their positions, 45 reducing their positions, and 12 closing their positions.

Holders
164
Holders Change
+20
Holders Change %
+13.89%
% of All Funds
2.4%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
33
Increased
60
Reduced
45
Closed
12
Calls
$20.5M
Puts
$28.8M
Net Calls
-$8.34M
Net Calls Change
-$8.63M

Top Buyers

1
EAM
1
Eventide Asset Management
Massachusetts
$144M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$109M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$257M
4
Morgan Stanley
4
Morgan Stanley
New York
$52.2M
5
Marshall Wace
5
Marshall Wace
United Kingdom
$50.8M

Top Sellers

1
RG
1
Redmile Group
California
$39.4M
2
KCM
2
Kynam Capital Management
New Jersey
$119M
3
Millennium Management
3
Millennium Management
New York
$436K
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$9.14M
5
ACP
5
Acuta Capital Partners
California
$2.75M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$280M 7,050,409 -38,711 -0.5%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$257M 6,476,561 +1,044,728 +19%
BlackRock
3
BlackRock
New York
$146M 3,675,692 +423,738 +13%
EAM
4
Eventide Asset Management
Massachusetts
$144M 3,630,013 +2,030,013 +127%
RI
5
RTW Investments
New York
$137M 3,463,201 – –
PCH
6
Polar Capital Holdings
United Kingdom
$124M 3,135,871 +709,115 +29%
Vanguard Group
7
Vanguard Group
Pennsylvania
$121M 3,046,331 +427,827 +16%
KCM
8
Kynam Capital Management
New Jersey
$119M 3,005,904 -194,096 -6%
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$109M 2,756,122 +1,413,722 +105%
BG
10
Bellevue Group
Switzerland
$95.8M 2,416,296 +516,296 +27%
State Street
11
State Street
Massachusetts
$94.3M 2,377,326 +84,475 +4%
Pictet Asset Management
12
Pictet Asset Management
Switzerland
$88.3M 2,225,448 +374,478 +20%
Morgan Stanley
13
Morgan Stanley
New York
$52.2M 1,316,730 +793,030 +151%
Marshall Wace
14
Marshall Wace
United Kingdom
$50.8M 1,280,084 +741,765 +138%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$44.3M 1,117,994 +117,569 +12%
RG
16
Redmile Group
California
$39.4M 993,803 -642,135 -39%
RSCM
17
Rock Springs Capital Management
Maryland
$38.5M 969,646 +469,545 +94%
SI
18
Sofinnova Investments
California
$33.5M 844,008 +419,749 +99%
EP
19
Eversept Partners
New York
$29.9M 754,107 +165,964 +28%
OCA
20
Octagon Capital Advisors
New York
$28.1M 707,526 -52,372 -7%
CC
21
Commodore Capital
New York
$27.8M 701,967 -4,698 -0.7%
5VM
22
5AM Venture Management
California
$19.7M 497,270 +187,000 +60%
Northern Trust
23
Northern Trust
Illinois
$17.6M 444,805 -29,115 -6%
Goldman Sachs
24
Goldman Sachs
New York
$17.4M 437,759 +25,925 +6%
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
$16.7M 422,293 -45,762 -10%
1
2 3 4 5